• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Expert Offers Surveillance, Lifestyle Guidance After CRC, Anal Cancer

by MM360 Staff | May 22, 2025 | Uncategorized

Source: CureToday articles Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer. Read More

Contemplating AI Assistance as a Cancer Survivor

by MM360 Staff | May 22, 2025 | Uncategorized

Source: CureToday articles Post Content Read More

FDA’s ODAC Votes Against Targeted Therapies in Bladder and Prostate Cancer

by MM360 Staff | May 22, 2025 | Uncategorized

Source: CureToday articles The FDA’s ODAC has voted against the risk/benefit profile of two targeted therapies for the treatment of bladder and prostate cancer, respectively. Read More

PMB-CT01 Therapy Induces Complete Remission in Follicular Lymphoma

by MM360 Staff | May 22, 2025 | Uncategorized

Source: CureToday articles A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment in the phase 1 PMB-102 trial. Read More

Intra-Arterial Paraplatin Shows No Hearing Loss in Retinoblastoma

by MM360 Staff | May 22, 2025 | Uncategorized

Source: CureToday articles DPOAE testing showed no hearing loss in children with retinoblastoma treated with intra-arterial paraplatin, suggesting preserved cochlear function. Read More

A Trailblazer in Oncology Nursing and Research

by MM360 Staff | May 21, 2025 | Uncategorized

Source: CureToday articles Gayle S. Jameson, M.S.N, ACNP-BC, AOCN, is a trailblazer whose expertise and compassion have made a profound impact on oncology care. Read More
« Older Entries
Next Entries »

Recent Content

  • Ambulatory Pharmacy in Action: House Calls and Harm Reduction Clinics Expand the Reach of Care
  • Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer
  • Reimagining Pain Management: Pharmacists Urged to “Deconstruct the Cupcake”
  • Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care
  • Targeted Chemo Improves Survival in Early-Stage Lung Cancer
  • Utilizing AI in Prostate Cancer Care and Management
  • KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT